Nailesh Bhatt
Director, Sonnet BioTherapeutics Holdings, Inc.
Companies
- Hyperliquid StrategiesBoard member Dec 12, 2025 to now1
- Sonnet BioTherapeutics Holdings, Inc.Board member Apr 3, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Hyperliquid Strategies PURR46,914 shares3$459.8K at $9.80Jul 1, 2026- Sonnet BioTherapeutics Holdings, Inc.0 shares4Dec 2, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Granted 1,588 shares of Hyperliquid Strategies3
- Apr 1, 2026Granted 2,455 shares of Hyperliquid Strategies5
- Feb 9, 2026Granted 40,789 shares of Hyperliquid Strategies6
- Dec 2, 2025Returned to company 10,547 shares of Sonnet BioTherapeutics Holdings, Inc.4
- Dec 2, 2025Other 2,082 shares of Hyperliquid Strategies7
- Jul 11, 2025Granted 10,000 shares of Sonnet BioTherapeutics Holdings, Inc.8
- Dec 11, 2023Granted 373 shares of Sonnet BioTherapeutics Holdings, Inc.9
- May 17, 2023Bought 25,000 shares at $0.23 of Sonnet BioTherapeutics Holdings, Inc.10
- Dec 14, 2022Granted 3,770 shares of Sonnet BioTherapeutics Holdings, Inc.11
- Dec 15, 2021Granted 14,152 shares of Sonnet BioTherapeutics Holdings, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARHyperliquid Strategies, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Apr 2, 2026
- 6SEC EDGARForm 4 filed Feb 11, 2026
- 7SEC EDGARForm 4 filed Dec 12, 2025
- 8SEC EDGARForm 4 filed Jul 15, 2025
- 9SEC EDGARForm 4 filed Dec 5, 2024
- 10SEC EDGARForm 4 filed May 18, 2023
- 11SEC EDGARForm 4 filed Dec 22, 2022
- 12SEC EDGARForm 4 filed Apr 8, 2022